Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Selig Enterprises pursues second phase of development at The Works, looking to complete its 80-acre mixed-use vision. The Works in west Midtown is shown, Friday, Dec. 19, 2025, in Atlanta. The Works ...